PRRT2 and early-onset autosomal dominant Alzheimer disease: Finally, the PKA/PKC modulation as a therapeutic approach for other neurodegenerative diseases such as cerebral ischemic/stroke and Alzheimer’s Disease was previously demonstrated31–33.